glp-1 timeline Glucagon-like peptide-1 receptor: mechanisms and advances in therapy A timeline of GLP- 1

Clinical evidence shows that 10% weight loss correlates with 50% reduction in knee arthritis painmeaning the pain relief is a direct result of the weight loss itself, not a separate effect of the medication

HbA1c improvements are typically assessed at 3 months after starting treatment and following each dose escalation

GLP-1 receptor in pancreatic A-cells regulates glucagon secretion in a glucose-dependent bidirectional manner

L-Glutathione is a powerful antioxidant that supports skin health that works from the inside out to reduce the visible signs of aging and help improve skin radiance and texture and pigmentation

Conclusion Glucagon-like peptide-1 receptor agonists modulate key pathways in human mesenchymal stem cells to influence survival, differentiation, and metabolic function, suggesting promising therapeutic potential beyond glycemic control